1
Planning Insulin workshop
V 29 July 2020
Increasing Availability and Affordability of Insulin and associated devices
Virtual workshops
21, 23, 24, 25 September 2020
14h – 16h CET
With the objective of “HEALTH FOR ALL” as the WHO’s guiding principle, WHO will organize a
multisectoral stakeholder workshop to initiate a dialogue with all relevant stakeholders to identify
elements that are critical to increasing availability and affordability of quality assured insulins and
associated devices.
Main Objectives and Outputs
This workshop will inform WHO’s global objectives to increase availability and affordability of quality-assured
insulin, insulin-delivery and glucose monitoring devices. It will increase visibility and awareness of the extent of the
barriers to access quality-assured insulins and identify possible solutions through the collaborative efforts and the
input of multisectoral stakeholders..
The workshop will assist WHO in achieving the following outputs:
1) Assess current global and regional status of diabetes care and need for insulin in terms of types,
volume and associated devices
2) Identify elements that are critical in increasing availability and affordability of quality assured
insulin, insulin-delivery and glucose monitoring devices
3) Identify bottlenecks in supply chain as well as management of cold-chain
4) Understand procurement issues
5) Agreements on approaches to regulatory requirements needed for registration of insulin and
glucose monitoring devices
6) Facilitate prequalification of 5 to 10 insulins by end of 2021 to increase competition
7) Identify how WHO and partners can work in an integrated manner towards these common goals
8) Agree on elements for the WHO integrated action plan to increase access to quality-assured
insulin and associated devices
Following topics will be discussed:
1) Overview of Diabetes Mellitus
Global impact of diabetes and WHO guidance on management
2) Briefing on market situation
Highlights from factsheets on prices and availability of insulin, insulin delivery devices, glucometers
and test strips
3) Challenges in accessing insulin and associated devices: Views from countries and patients
• need for health care professionals
• what are the existing training programmes
• why thermostability of insulin is important
4) Challenges in procurement and supply chain
5) Programmatic Initiatives
6) NRAs roles and perspective on ensuring quality-assured insulin
7) Exploring opportunities for partnerships and collaboration
Saatja: LINDHARDT, Lisbeth Sjaelborg <
[email protected]>
Saadetud: 01.09.2020 11:33
Adressaat: Elen Ohov <
[email protected]>
Koopia: Triin Uusberg <
[email protected]>; SM Info <
[email protected]>;
<
[email protected]>; <
[email protected]>; KÖHLER, Kristina
<
[email protected]>; PIRGARI, Dorina <
[email protected]>
Teema: EST Increasing Availability and Affordability of Insulin and
associated devices, Virtual workshops, 21, 23, 24, 25 September 2020
Please see the attached correspondence sent from the World Health
Organization, Regional Office for Europe. One or more attachments may be
included.Veuillez vous r¨¦f¨¦rer ¨¤ la correspondance ci-jointe du Bureau
r¨¦gional de l'Europe de l'Organisation mondiale de la sant¨¦. Une ou
plusieurs annexes peuvent ¨ºtre jointes.Mit der Bitte um Kenntnisnahme
der beiliegenden Korrespondenz (eine oder mehrere Anlagen),
Weltgesundheitsorganisation, Regionalb¨¹ro f¨¹r Europa.
§³§Þ. §á§â§Ú§Ü§â§Ö§á§Ý§Ö§ß§ß§à§Ö §á§Ú§ã§î§Þ§à §à§ä
§¦§Ó§â§à§á§Ö§Û§ã§Ü§à§Ô§à §â§Ö§Ô§Ú§à§ß§Ñ§Ý§î§ß§à§Ô§à §Ò§ð§â§à
§£§ã§Ö§Þ§Ú§â§ß§à§Û §à§â§Ô§Ñ§ß§Ú§Ù§Ñ§è§Ú§Ú §Ù§Õ§â§Ñ§Ó§à§à§ç§â§Ñ§ß§Ö§ß§Ú§ñ
(§à§Õ§Ú§ß §Ú§Ý§Ú §ß§Ö§ã§Ü§à§Ý§î§Ü§à §á§â§Ú§Ü§â§Ö§á§Ý§Ö§ß§ß§í§ç
§æ§Ñ§Û§Ý§à§Ó).
Regards,
Dorina Pirgari DSP/HTP/WHO EURO
Tel. +45 45 33 71 07
Mob. +45 91 98 66 95
E-mail:
ORLD HEALTH ORGANIZATION
ORGANISATION MONDIALE DE LA SANTÉ
WELTGESUNDHEITSORGANISATION Date: 31 August 2020
ВСЕМИРНАЯ ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ
REGIONAL OFFICE FOR EUROPE Ms Elen Ohov
BUREAU RÉGIONAL DE L’EUROPE
REGIONALBÜRO FÜR EUROPA
Adviser
ЕВРОПЕЙСКОЕ РЕГИОНАЛЬНОЕ БЮРО European Union Affairs and International Co-
Head office:
operation Department
UN City, Marmorvej 51, Ministry of Social Affairs
DK-2100 Copenhagen Ø, Denmark Suur-Ameerika 1
Tel.: +45 45 33 70 00; Fax: +45 45 33 70 01
Email:
[email protected] Tallinn 10122
Website: http://www.euro.who.int Estonia
Email:
[email protected]
Dear Ms Ohov,
WHO live workshop on increasing the availability and affordability of quality-assured insulins
and associated devices, 21, 23, 24, 25 September 2020
We have the honour to inform you that the World Health Organization is holding a live webinar on
increasing the availability and affordability of quality-assured insulins and associated devices on 21,
23, 24, 25 September 2020.
With the objective of “HEALTH FOR ALL” as WHO’s guiding principle, WHO will organize a
multisectoral stakeholder workshop to initiate a dialogue with all relevant stakeholders. This aims to
identify elements that are critical to increasing the availability and affordability of quality-assured
insulins and associated devices.
I have the pleasure of inviting you to nominate one or two participants (candidates) from your
country, representing the following institutions:
• one representative from the National Regulatory Authority (NRA) who has an in-depth
knowledge of, and experience in evaluation of biopharmaceutical products, including insulins
and biosimilars; and/or
• one representative from the Ministry of Health (MoH), who has an in-depth understanding of
success and bottlenecks in accessing quality-assured insulins and is well informed on the
pricing and affordability mechanisms that are in place to ensure affordable access.
The working language of the workshop will be English. The workshop will be streamed on 21, 23, 24,
25 September 2020 from 14:00 to 16:00 CET.
We look forward to receiving your nominations, stating the names, functional titles and contact details
(including e-mail address) of the proposed participants, at the latest by 11 September 2020. The
required information should be directed to Dorina Pirgari (
[email protected]), Health Technologies,
and Pharmaceuticals Programme, WHO Regional Office for Europe. We will then communicate with
UN City, Marmorvej 51 Tel.: +45 45 33 70 00 Email:
[email protected]
DK-2100 Copenhagen Ø Fax: +45 45 33 70 01 Website: http://www.euro.who.int
Denmark
the nominees directly and provide them with the necessary documentation and administrative
information in good time.
Should you have questions or need any further information, please do not hesitate to contact us.
Yours faithfully,
Dr Natasha Azzopardi Muscat
Director
Division of Country Health Policies and Systems
Copy for information to:
Ms Triin Uusberg, Head, European and International Coordination Department, Ministry of Social Affairs, Suur-Ameerika
1, Tallinn 10129, Estonia, Email:
[email protected],
[email protected]
H.E. Ms Katrin Saarsalu-Layachi, Ambassador Extraordinary and Plenipotentiary, Permanent Representative, Permanent
Mission of the Republic of Estonia to the United Nations Office and other international organizations in Geneva, Chemin
du Petit-Saconnex 28A, Genève CH-1209, Switzerland, Email:
[email protected]
H.E. Mr William Mart Laanemäe, Ambassador Extraordinary and Plenipotentiary, agréé, Embassy of the Republic of
Estonia, Frederiksgade 19, 4th floor, Copenhagen K 1265, Denmark, Email:
[email protected]
Ms Kristina Köhler, Liaison Officer, WHO Country Office, Estonia, Paldiski Road 81, Tallinn 10617, Estonia, Email:
[email protected]
–2–